Martijn B. A. van Doorn

Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families

Arjan C. Houweling, Lieke Gijezen, Marianne A. Jonker et al. · British Journal of Cancer · 2011 · 162 citations · Full text

Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial

Alice B. Gottlieb, John Sullivan, Martijn B. A. van Doorn et al. · Journal of the American Academy of Dermatology · 2016 · 150 citations · Full text

Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis

L.L.A. Lecluse, R.J.B. Driessen, Phyllis I. Spuls et al. · Archives of Dermatology · 2010 · 147 citations · Full text

Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial

Allard R.J.V. Vossen, Martijn B. A. van Doorn, Hessel H. van der Zee et al. · Journal of the American Academy of Dermatology · 2018 · 127 citations

Moderate Hidradenitis Suppurativa, Allergy, Clinical Dermatology +3

Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers

Martijn B. A. van Doorn, Jack Vogels, Albert C. Tas et al. · British Journal of Clinical Pharmacology · 2006 · 125 citations · Full text